PD-L1, existing on the surface of various cell types including epithelial cells and tumor cells, can bind with PD-1 on the surface of T cells to act as the key immune checkpoint mediator in healthy conditions; however, it can also suppress the immune response of cytotoxic T cells in cancer. Here, CD274 is linked to cancer.